Waxy-Maize HES 130/0.4; evidence based clinical decisionsFootnote

Peer review under responsibility of Egyptian Society of Anesthesiologists.

References

• Schoch, T. J. The chemistry of hydroxyethyl starch. Second Conference on Artificial Colloidal Agents. 1963;121–8.
   Google Scholar
• M.WestphalM.JamesS.Kozek-LangeneckerR.StockerB.GuidetH.Van AkenHydroxyethyl starches; different products – different effectsAnesthesiology1112009187202
   PubMed Web of Science ®Google Scholar
• P.Van der LindenS.G.De HertD.DeraedtS.CromheeckeK.De DeckerR.De PaepHydroxyethyl starch 130/0.4 versus modified fluid gelatin for volume expansion in cardiac surgery patients: the effects on perioperative bleeding and transfusion needsAnesth Analg1012005629634
   Web of Science ®Google Scholar
• S.M.KasperP.MeinertS.KampeC.GörgC.GeisenU.MehlhornLarge dose hydroxyethyl starch 130/04 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200/05 at recommended dosesAnesthesiology9920034247
   Web of Science ®Google Scholar
• B.EllgerJ.FreyhoffH.Van AkenM.BookeM.A.MarkusHigh dose volume replacement using HES 130/0.4 during major surgery. Impact on coagulation and incidence of postoperative itchingNeth Tijdschr Anesth1920066368
   Google Scholar
• C.HanartM.KhalifeA.De Ville´F.OtteS.De HertP.Van der LindenPerioperative volume replacement in children undergoing cardiac surgery: albumin versus hydroxyethyl starch 130/0.4Crit Care Med372009696701
   PubMed Web of Science ®Google Scholar
• T.A.NeffM.DoelbergC.JungheinrichA.SauerlandD.R.SpahnR.StockerRepetitive large-dose infusion of the novel hydroxyethyl starch 130/0.4 in patients with severe head injuryAnesth Analg96200314531459
   Web of Science ®Google Scholar
• A.MukhtarF.AboulfetouhG.ObayahM.SalahM.EmamY.KhaterThe safety of modern hydroxyethyl starch in living donor liver transplantation: a comparison with human albuminAnesth Analg10932009924930
   Web of Science ®Google Scholar
• V.V.LomivorotovV.A.ShmyrevS.M.EfremovEfficiency of using gelofusine and voluven in acute normovolemic haemodilution during cardiosurgical interventionsAnesteziol Reanimatol320081013
   Google Scholar
• A.DubinM.PozoC.CasabellaG.MuriasF.PálizasJr.M.MoseincoComparison of 6% hydroxyethyl starch 130/0.4 and saline solution for resuscitation of the microcirculation during the early goal-directed therapy of septic patientsJ Crit Care254201018
   Google Scholar
• S.J.ChoiJ.K.ShimS.W.HongComparing the effects of 5% albumin and 6% hydroxyethyl starch 130/0.4 on coagulation and inflammatory response when used as priming solutions for cardiopulmonary bypassMinerva Anestesiol7682010584591
   Web of Science ®Google Scholar
• C.WangH.JiangZ.ZhangEffects of hydroxyethyl starch 130/0.4 on intraabdominal hypertension in patients with severe acute pancreatitis2009WCACSDublin Ireland
   Google Scholar
• J.ZhouJ.Y.ZhongH.LiEffect of 6% hydroxyethyl starch 130/0.4 on renal function in patients undergoing cardiac valve replacement with cardiopulmonary bypassChin J New Drugs Clin Rem7272008504507
   Google Scholar
• J.ZhouC.X.YangA.Z.LinHydroxyethyl starch 130/0.4 inhibiting nuclear factor kappa B activity of neutrophils in patients undergoing cardiac valve replacement with cardiopulmonary bypassChin J New Drugs Clin Rem28122009900904
   Google Scholar
• B.NohéT.JohannesJ.ReutershanSynthetic colloids attenuate leukocyte-endothelial interactions by inhibition of integrin functionAnesthesiology10342005759767
   Web of Science ®Google Scholar
• C.A.VoltaV.AlvisM.CampiE.MarangoniR.AlvisM.CastellazziInfluence of different strategies of volume replacement on the activity of matrix metalloproteinases: an in vitro and in vivo studyAnesthesiology106120078591
   Web of Science ®Google Scholar
• A.Di FilippoM.CiapettiD.PrencipeExperimentally-induced acute lung injury: the protective effect of hydroxyethyl starchAnn Clin Lab Sci3632006345352
   Web of Science ®Google Scholar
• H.J.DieterichT.WeissmüllerP.RosenbergerEffect of hydroxyethyl starch on vascular leak syndrome and neutrophil accumulation during hypoxiaCrit Care Med346200617751781
   Web of Science ®Google Scholar
• N.DingH.XiaoLx.XuEffect of hydroxyethyl starch 130/0.4 on ICAM-1 expression in endotoxin-induced acute lung injury in rats and role of MAPK signal pathway in its expressionZongguo Yaolixue Tongbao2532009394398
   Google Scholar
• X.FengY.HuJ.DingEarly treatment with hydroxyethyl starch 130/0.4 causes greater inhibition of pulmonary capillary leakage and inflammatory response than treatment instituted later in sepsis induced by cecal ligation and puncture in ratsAnn Clin Lab Sci37120074956
   Web of Science ®Google Scholar
• X.FengJ.LiuM.YuProtective roles of hydroxyethyl starch 130/0.4 in intestinal inflammatory response and survival in rats challenged with polymicrobial sepsisClin Chim Acta3761–220076067
   PubMed Web of Science ®Google Scholar
• D.PalumboG.ServilloL.D’AmatoM.L.VolpeG.CapogrossoE.De robertisThe effects of hydroxyethyl starch solution in critically ill patientsMinerva Anestesiol722006655664
   Web of Science ®Google Scholar
• M.G.VidalJ.Ruiz WeisserF.GonzalezIncidence and clinical effects of intra-abdominal hypertension in critically ill patientsCrit Care Med366200818231831
   Web of Science ®Google Scholar
• T.StandlM.A.BurmeisterF.SchroederE.CurrlinJ.Schulte am EschM.FreitagHydroxyethyl starch (HES) 130/0.4 provides larger and faster increases in tissue oxygen tension in comparison with prehemodilution values than HES 70/0.5 or HES 200/0.5 in volunteers undergoing acute normovolemic hemodilutionAnesth Analg962003936943
   PubMed Web of Science ®Google Scholar
• J.WaitzingerF.BepperlingG.PabstJ.OpitzHydroxyethyl starch (HES) [130/0.4], a new HES specification. Pharmacokinetics and safety after multiple infusions of 10% solution in healthy volunteersDrugs RD42003149157
   Google Scholar
• S.A.Kozek-LangeneckerC.JungheinrichW.SauermannP.J.Van der LindenThe effects of hydroxyethyl starch 130/0.4 (6%) on blood loss and use of blood products in major surgery: a pooled analysis of randomized clinical trialsAnesth Analg1072008382390
   Web of Science ®Google Scholar
• C.JungheinrichR.ScharpfM.WargenauF.BepperlingJ.-F.BaronThe pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethyl starch 130/0.4 (6%, 50.0 ml) in mild-to-severe renal impairmentAnesth Analg952002544551
   Web of Science ®Google Scholar
• http://www.fda.gov/bbs/topics/NEWS/2007/NEW01765.html.
   Google Scholar
• Cochrane Injuries Group albumin Reviewers. Human albumin administration in critically ill patients: systematic review of randomized controlled trials. Cochrane Injuries Group Albumin Reviewers. BMJ 1998;317:235–40.
   Google Scholar
• SAFE Study InvestigatorsS.FinferR.BellomoS.McEvoyEffect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) studyBMJ33320061044
   PubMed Web of Science ®Google Scholar
• Product information leaflet of HA solution & HES 130/0.4.
   Google Scholar
• Sucre MJ, Camino G, Piccolo M, De Nicola A. Effectiveness of volume preload before spinal anaesthesia for caesarean section: 6% hydroxyethyl starch 130/0.4 versus lactated Ringer’s solution. S204, WCA 2004.
   Google Scholar
• J.S.KoC.S.KimH.S.ChoD.H.ChoiA randomized trial of crystalloid versus colloid solution for prevention of hypotension during spinal or low-dose combined spinal-epidural anesthesia for elective cesarean deliveryInt J Obstet Anesth162007812
   PubMed Web of Science ®Google Scholar
• Barbe E, Lewi L, De Buck F, Vandermeersch E, Van De Velde M: Combined spinal epidural analgesia during labour: Does prophylactic intravenous colloid infusion reduce the incidence of hypotension? Acta Anaesthesiologica Belgica, 2007;58:2
   Google Scholar
• S.Madi-JebaraA.GhosnG.SleilatyF.RichaA.CherfaneF.HaddadPrevention of hypotension after spinal anesthesia for cesarean section 6% hydroxyethyl starch 130/0.4 (Voluven®) versus lactated ringer’s solutionLebanese Med J5642008203
   Google Scholar
• S.SiddikV.NasrS.TahaR.ZbeideJ.M.ShehadeA.AlamiA randomized trial comparing colloid preload to coload during spinal anesthesia for elective cesarean deliveryAnesth Analg10942009
   Web of Science ®Google Scholar
• C.Fenger-EriksenC.Hartig RasmussenT.Kappel JensenE.Anker-MøllerJ.HeslopJ.FrøkiaerRenal effects of hypotensive anaesthesia in combination with acute normovolaemic haemodilution with hydroxyethyl starch 130/0.4 or isotonic salineActa Anaesthesiol Scand492005969974
   Web of Science ®Google Scholar
• G.GodetJ.J.LehatG.JanvierA.SteibV.de CastroP.CoriatSafety of HES 130/0.4 (Voluven®) in patients with preoperative renal dysfunction undergoing abdominal aortic surgery: a prospective, randomized, controlled, parallel-group multicentre trialEur J Anaesthesiol252008986994
   Web of Science ®Google Scholar
• A.MahmoodP.GoslingR.K.VohraRCT comparing the effects on renal function of hydroxyethyl starch or gelatine during aortic aneurysm surgeryBr J Surg942007427433
   PubMed Web of Science ®Google Scholar
• Blasco V, Leone M, Antonini F, Geissler A, Albanese J, Martin C. Comparison of the novel hydroxyethylstarch 130/0.4 and hydroxyethylstarch 200/0.6 in brain-dead donor resuscitation on renal function after transplantation. Br J Anaesth BJA 2008 [Advance Access published February 6].
   Google Scholar
• Y.Y.DengY.KangX.L.LiaoInfluence of hydroxyethyl starch 130/0.4 on renal function of injured patients with acute renal failure after Wenchuan earthquakeChin Crit Care Med2122009114116
   Google Scholar
• J.L.JoverJ.P.GarciáC.MartínezA.EspíE.GregoriJ.AlmagroUse of hydroxyethyl starch (Voluven®) to protect renal function in laparoscopic surgeryRev Esp Anestesiol Reanim5620092730
   Google Scholar
• F.SchabinskiJ.OishiF.TucheA.LuyY.SakrD.BredleEffects of a predominantly hydroxyethyl starch (HES)-based and a predominantly non HES-based fluid therapy on renal function in surgical ICU patientsIntensive Care Med359200915391547
   Web of Science ®Google Scholar
• J.S.OoiA.R.RamzishamM.D.ZamrinIs 6% hydroxyethyl starch 130/0.4 safe in coronary artery bypass graft surgery?Asian Cardiovasc Thorac Ann172009368372
   PubMedGoogle Scholar
• M.PavlidisS.PoulouC.PalumbiA.MantziokaK.TsinariSafety of hydroxyethyl starch (HES 130/0.4) in patients undergoing cadaver kidney transplantation Eur J Anaesthesiol. Euroanaesthesia 2009, The European Anaesthesiology CongressMilanJune 6–92009
   Google Scholar
• I.KiesowD.PavlovicS.O.KuhnC.LehmannM.WendtVolume replacement therapy with HAES 130/0.4 does not influence rate of renal failure in septic patients InfectionInfection37Suppl. 3200950
   Google Scholar
• N.BoussekeyR.DarmonJ.LangloisS.AlfandariP.DevosA.MeybeckResuscitation with low volume hydroxyethylstarch 130 kDa/0.4 is not associated with acute kidney injuryCrit Care1422010R40
   Web of Science ®Google Scholar
• F.M.BrunkhorstC.EngelF.BloosA.Meier-HellmannM.RagallerN.WeilerIntensive insulin therapy and Pentastarch resuscitation in severe sepsisNew Engl J Med3582008125139
   PubMed Web of Science ®Google Scholar
• M.L.MalbrainD.ChiumelloP.PelosiIncidence and prognosis of intraabdominal hypertension in a mixed population of critically ill patients: a multiple-center epidemiological studyCrit Care Med332005315322
   PubMed Web of Science ®Google Scholar
• <http://www.clinicaltrial.gov/ct2/show/NCT00694343>.
   Google Scholar
• M.KhalifeC.HanartA.de VilleS.de HertP.van der Linden6% HES 130/0.4 versus 4% albumin for volume replacement in paediatric cardiac surgery: cyanotic congenital diseaseEur J Anaesthesiol232006A-300
   Google Scholar
• H.LochbühlerC.GalliH.HagemannHydroxyethyl starch HES 130/0.4 in paediatric surgery: results of an explorative, controlled, multicenter safety studyCrit Care Med7Suppl. 22003107
   Google Scholar
• T.StandlH.LochbuehlerC.GalliA.ReichG.DietrichH.HagemannHES 130/0.4 (Voluven®) or human albumin in children younger than 2 yr undergoing non-cardiac surgery. A prospective, randomized, open label, multicentre trialEur J Anaesthesiol252008437445
   PubMed Web of Science ®Google Scholar
• I.A.SavvinaIntraoperative Voluven® use in paediatric neurosurgical patientsIntensive Care Med29Suppl. 12003604
   Google Scholar
• K.C.SungP.K.SukY.M.JaEffects of intravascular volume therapy using hydroxyethyl starch (130/0.4) on post-operative bleeding and transfusion requirements in children undergoing cardiac surgery: a randomized clinical trialActa Anaesthesiol Scand502006108111
   Web of Science ®Google Scholar
• S.SaudanM.PellegriniD.CeroniHydroxyethyl starch 130/0.4 versus albumin in children undergoing spinal fusion: safety and efficiencyEur J Anaesthesiol23Suppl. 372006A662
   Google Scholar
• Haljamae Hengo: perioperative advances in colloid therapy. In: 6th annual NATA symposium, April; 2005.
   Google Scholar
• G.V.SudhakarP.LakshmiRole of HES 130/0.4 in resuscitation of patients with major burn injuryTransfus Altern Transfus Med1020084350
   Google Scholar
• N.P.ShenV.M.EgorovF.N.BrezginInfusion therapy for burn shock in childrenAnesteziol Reanimatol Anaestesiol Intensive Care12200623
   Google Scholar
• W.ThornS.MohazzebMolecular weights, lengths and distribution of side-chains in d-polyglucanesStarch/Stärke42101990373376
   Web of Science ®Google Scholar
• K.SommermeyerF.CechM.SchmidtKlinisch verwendete Hydroxyethylstärke: Physikalisch-chemische CharakterisierungKrankenhauspharmazie81987271278
   Google Scholar
• A.BlennowS.B.EngelsenL.MuncStarch molecular structure and phosphorylation investigated by a combined chromatographic and chemometric approachCarbohydr Polym412000163174
   Web of Science ®Google Scholar
• O.SanderK.ReinhartA.Meier-HelmannEquivalence of hydroxyethyl starch HES 130/0.4 and HES 200/0.5 for perioperative volume replacement in major gynaecological surgeryActa Anaesthesiol Scand47200311511158
   Web of Science ®Google Scholar
• M.LaxenaireC.CharpentierL.FeldmanLe Group Francais d’Etude, de la Tole´rance des Substituts Plasmatiques: anaphylactoid reactions to colloid plasma substitutes: frequency, risk factors, mechanisms. A French multicenter prospective studyAnn Fr Anesth Re´anim131994301310
   Web of Science ®Google Scholar